Highmark

Health plans explain genetic testing coverage decisionsToday there are nearly 67,000 genetic tests. With so many tests available, it can be difficult for MCOs to determine what to cover.
Four innovative models rein in pharma costs
Four innovative models rein in pharma costsPlans and PBMs are finding new ways to rein in pharmacy costs.
New cancer care approach: Highmark’s cancer collaborativeCancer care has made great strides in the U.S., but effective care is still too expensive and inaccessible for many Americans. Now, payers and providers at Highmark, Allegheny Health Network and Johns Hopkins are launching a new model that could change cancer collaboration.
Highmark aims to shore up ACA business after lossesFollowing on the heels of UnitedHealthcare, Highmark weighs whether staying on the exchange marketplace will be viable.
Consumerism increases retail opportunities and access to coverage and care
Consumerism increases retail opportunities and access to coverage and careSpurred on by the Affordable Care Act, retailers, health plans and providers are staking strong retail positions that are increasing coverage opportunities and access to care.
Need to Know: June 2014Industry updates in business and health management
Need to Know: April 2014Industry updates in business and health management
Plan nixes markup on cancer drugsPayment changes will save an estimated $200 million annually.
Blues plans merge to gain leverageHighmark will become the Blue affiliate for BCNEPA’s 13-county service area.
IOM core competencies focus on collaborative careAs health systems become more integrated, health plan pharmacy directors are finding themselves in a more collaborative role, taking on new responsibilities that break them out of the mold of the traditional pharmacist